Salvage of the proximal femur following pathological fractures involving benign bone tumors

2016 ◽  
Vol 114 (2) ◽  
pp. 254-254
Author(s):  
Abhijeet Ashok Salunke ◽  
Jaymin Shah ◽  
Vikas Warikoo ◽  
Ramesh Kumar ◽  
Ashok Galande ◽  
...  
Keyword(s):  
Proximal Femur ◽  
Bone Tumors ◽  
Pathological Fractures ◽  
Benign Bone Tumors

Salvage of the proximal femur following pathological fractures involving benign bone tumors

2015 ◽  
Vol 112 (8) ◽  
pp. 846-852 ◽  
Author(s):  
Pedro I. Carvallo ◽  
Anthony M. Griffin ◽  
Peter C. Ferguson ◽  
Jay S. Wunder
Keyword(s):  
Proximal Femur ◽  
Bone Tumors ◽  
Pathological Fractures ◽  
Benign Bone Tumors

Pathologic Fractures of the Proximal Femur Secondary to Benign Bone Tumors

2001 ◽  
Vol 393 ◽  
pp. 279-286 ◽  
Author(s):  
Eugene K. Wai ◽  
Aileen M. Davis ◽  
Anthony Griffin ◽  
Robert S. Bell ◽  
Jay S. Wunder
Keyword(s):  
Proximal Femur ◽  
Bone Tumors ◽  
Benign Bone Tumors ◽  
Pathologic Fractures

scholarly journals Strategies for managing the destruction of calcar femorale

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Jin Mei ◽  
Lili Pang ◽  
Zhongchao Jiang
Keyword(s):  
Proximal Femur ◽  
Bone Tumors ◽  
Bone Cyst ◽  
Treatment Strategies ◽  
Femoral Neck Fractures ◽  
Anatomical Structure ◽  
Pathological Fractures ◽  
Main Text ◽  
Primary Bone Tumors ◽  
Primary Bone

Abstract Background The calcar femorale was identified long ago. However, our current understanding of the calcar is insufficient, and its related concepts are sometimes confused. The calcar femoral is an important anatomical structure of the proximal femur, and its function can be overlooked. In trauma, tumors, or other diseases, the calcar femorale can be destroyed or changed pathologically. As a result, the mechanical structure of the proximal femur becomes destroyed, causing pathological fractures. How to address the destruction of the calcar femorale or the damage to the calcar femorale is discussed in this article. Main text Destruction of the calcar femorale is accompanied by many conditions, including trauma, tumors, and other diseases. The types of hip fractures caused by trauma include femoral neck fractures and intertrochanteric fractures. Dynamic hip screws, proximal femoral nail anti-rotation, and multiple parallel cannulate pins can be used in different conditions. When metastatic and primary bone tumors involve the calcar femorale, endoprostheses are widely used. Other diseases, such as fibrous dysplasia and aneurysmal bone cyst are treated differently. Conclusions The calcar femorale can redistribute stresses and the destruction of the calcar femorale can lead to an increase in posterior medial stress. Many factors need to be considered when deciding whether to reconstruct the calcar femorale. Effective treatment strategies for managing the destruction of calcar femorale will need first establishing the precise mechanism of the destruction of the calcar and then designing therapies towards these mechanisms. Further investigation to the calcar needs to be carried out.

MALIGNANT AND BENIGN BONE TUMORS

2001 ◽  
Vol 39 (4) ◽  
pp. 673-699 ◽  
Author(s):  
Shannon L. Miller ◽  
Fredric A. Hoffer
Keyword(s):  
Bone Tumors ◽  
Benign Bone Tumors

scholarly journals Preliminary results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions

Open Medicine ◽  
2018 ◽  
Vol 13 (1) ◽  
pp. 487-492 ◽  
Author(s):  
Daniel Kotrych ◽  
Szymon Korecki ◽  
Paweł Ziętek ◽  
Bartosz Kruk ◽  
Agnieszka Kruk ◽  
...  
Keyword(s):  
Bone Substitute ◽  
Bone Tumors ◽  
Bone Cyst ◽  
Bone Diseases ◽  
Long Term Results ◽  
Reconstructive Procedures ◽  
Benign Bone Tumors ◽  
Significant Clinical Improvement ◽  
Tumor Like Lesions

AbstractBackground: CERAMENT™|BONE VOID FILLER is an injectable and moldable ceramic bone substitute material intended for bone voids. The material consists of hydroxyapatite and calcium sulfate hemihydrate. The aim of this study is to present the first long-term results following open curettage of benign bone tumors and tumor-like lesions and void filling with this novel injectable and synthetic bone graft. Methods: Thirty three patients were enrolled into the study between June 2013 and October 2014 .Totally, we treated 24 women and 9 men with a median age of 47 years (range: 22-74). All patients suffered from primary musculoskeletal system disorders (enchondroma 63,6%, giant cell tumor 18%, aneurysmal bone cyst 9%, fibrous dysplasia 9%, Gaucher disease 3%). We performed curettage of pathological lesions, then the bone substitute was administered by means of needle to the void. Results: The average follow-up was 13 months (range: 2-13 months, median 10 months). No metastasis or recurrence had been detected. We received significant clinical improvement relating to VAS, MSTS, and oncological results. Conclusions: The results of our study report that CERAMENT can be successfully used as a bone substitute in patients with various bone diseases, as well as benign bone tumors. CERAMENT can provide an effective and long-term solution for reconstructive procedures following curettage of bone tumors and tumor like lesions.

Benign Bone Tumors

2010 ◽  
pp. 48-49
Author(s):  
Javad Parvizi ◽  
Gregory K. Kim
Keyword(s):  
Bone Tumors ◽  
Benign Bone Tumors
Sign in / Sign up

Export Citation Format

Share Document